Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Oxoid Makes Screening For Antibiotic-Resistant Organisms Faster, Allowing For Swifter Infection Control And Patient Treatment
Oxoid, a world leading microbiology brand, has today announced the availability of two new chromogenic media in the Brilliance™ Resistant Screening Agar range. Brilliance ESBL Agar and Brilliance VRE Agar can be used as screening tests to rapidly identify patients colonised with problematic Extended Spectrum Beta-Lactamase (ESBL) producing organisms and vancomycin resistant enterococci (VRE), allowing appropriate infection control and treatment to commence sooner for the best possible patient outcome.
generic viagra online
What Is a Nail Fungal Infection? What Causes Nail Fungus Infections?
Also known as onychomycosis and tinea unguium, nail fungal infections are the most common diseases of the nails, making up about 50% of nail abnormalities. Both fingernails and toenails are susceptible to the infection, which usually manifests as discoloration and thickening of the nail and crumbling edges. The condition most commonly occurs in toenails.
News of the day
CEO Of Black AIDS Institute Discusses HIV/AIDS At Newspaper Conference; Group Releases Report Examining HIV Testing In Black Community
Phill Wilson, CEO of the Black AIDS Institute (BAI), last week addressed the annual convention of the National Newspapers Publishers Association where he discussed the reasons blacks "were so slow to grasp the severity of the threat" of HIV, the NNPA/Seattle Medium reports. According to Wilson, many blacks believed that HIV/AIDS was not directly affecting their communities in the early years of the epidemic. In addition, he said when AIDS reached its peak between 1980 and 1982, blacks also were dealing with unemployment, poverty and welfare reform and, as a result, addressing HIV/AIDS was not a priority. Wilson also noted the reluctance by blacks to deal with the stigma related to the virus. Wilson said, however, "I"m more optimistic now around mobilizing black folks around HIV than [ever] before. I think we"ve made tremendous stride[s] and our institutions across the board are at a different place than they were" (Curry, 7/1).
Health Insurance

Scrap England's "Shameful" Prescription Charge, Urges DTB

The prescription charge in England is a tax in all but name - and an unfair one at that - and should be axed, says Drug and Therapeutics Bulletin (DTB). England is the only one of the four UK countries that has either not already scrapped the charge or plans to do so by April 2011. DTB argues that, contrary to popular belief, the ÷£7.20 currently levied on prescription medicines does not directly reflect the cost of the drug prescribed and does not specifically fund health services. Instead, the charge is for raising general tax revenue, it says. With the abolition of the charge in Scotland, Wales, and Northern Ireland, a key argument put forward for its retention - namely that it reminds people of the cost of medicines, and acts as a deterrent to overuse prescription services - rings hollow, says DTB. "Why only people in England need such a reminder is far from clear," it says. Those who support the charge argue that many people are exempt. But these exemptions are totally illogical, says DTB. And they are so confusing that even NHS Prescription Services is setting up an online quiz for healthcare professionals to test their knowledge about whom they should and should not be charging. The other concern that advocates for the retention of the charge advance is that its abolition might prompt patients to demand medicines "of dubious value." The counter argument is that if these products are so questionable, they should not be available for prescription in the first place, insists DTB. Having demolished the arguments in support of keeping the prescription charge in England, DTB concludes: "[It] is a poorly conceived, manifestly unfair tax that shames the NHS and the Department of Health. It needs to go." Drug And Therapeutics Bulletin


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009